For patients who've plateaued on tirzepatide or semaglutide, one of the most evidence-based mostly up coming stage in 2026 is optimizing the current protocol. Adjusting dose timing, revisiting macronutrient distribution, or incorporating resistance coaching to preserve lean mass all through ongoing weight loss. Convey to your health practitioner